The 2017 State Science and Technology Awards ceremony was held at the Great Hall of the People in Beijing on 8 January, 2018. Two collaborative research projects participated in by The Chinese University of Hong Kong (CUHK), namely 'Development and Promotion of Molecular Targeted Therapy for Lung Cancer Patients', and 'Innovative Strategy and Technology for the Prevention and Treatment of Stroke', each received a State Scientific and Technological Progress Award (second-class). 

The project "Development and Promotion of Molecular Targeted Therapy for Lung Cancer Patients" was led by Prof. Tony Shu Kam MOK, Li Shu Fan Medical Foundation Professor of Clinical Oncology and Chairman of the Department of Clinical Oncology at the Faculty of Medicine at CUHK, and his collaborator Prof. Yi-Long WU with his team from Guangdong General Hospital at the Guangdong Academy of Medical Sciences in lung cancer researches. The research especially focuses on epidermal growth factor receptor (EGFR) mutation happening in patients with lung adenocarcinoma. With the success of these trials and developments, the team has helped define 'personalised medicine' for lung cancer in mainland China and the world. Their studies were used for the registration of multiple targeted drugs in mainland China, allowing thousands of patients to receive first-line EGFR targeted therapy drugs at low cost. 

The project "Innovative Strategy and Technology for the Prevention and Treatment of Stroke" was led by Prof. Lawrence Ka Sing WONG, Clinical Professor (honorary) of the Department of Medicine and Therapeutics at the Faculty of Medicine at CUHK, in collaboration with the Third Military Medical University and Chongqing Medical University. The research focuses on the prevention and treatment of stroke for many years. Professor Wong's team works on the epidemiology, pathogenesis and treatment of intracranial atherosclerosis. 

More details can be found at the University's press release here. Detailed list of CUHK's Honors & National Awards in the past years can be found here.